170 related articles for article (PubMed ID: 82495)
1. Human alpha2-macroglobulin and its antitrypsic and antithrombin activities in serum and plasma.
de Vonne TL; Mouray H
Clin Chim Acta; 1978 Nov; 90(1):83-5. PubMed ID: 82495
[TBL] [Abstract][Full Text] [Related]
2. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
Campo G; Modena N; Gallo A; Ciaffoni S
Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
[TBL] [Abstract][Full Text] [Related]
3. A new assay for the measurement of total progressive antithrombin.
Lane JL; Bird P; Rizza CR
Br J Haematol; 1975 May; 30(1):103-15. PubMed ID: 53064
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the inhibition of thrombin by three plasma protease inhibitors.
Downing MR; Bloom JW; Mann KG
Biochemistry; 1978 Jun; 17(13):2649-53. PubMed ID: 79421
[TBL] [Abstract][Full Text] [Related]
5. Thrombin inhibitors in women on oral contraceptives.
Guagnellini E; Bertolini G; Cappelletti M; Colombo G
Acta Haematol; 1981; 65(3):205-10. PubMed ID: 6165217
[TBL] [Abstract][Full Text] [Related]
6. Effect of anabolic steroids on plasma antithrombin III. alpha2 macroglobulin and alpha1 antitrypsin levels.
Walker ID; Davidson JF; Young P; Conkie JA
Thromb Diath Haemorrh; 1975 Sep; 34(1):106-14. PubMed ID: 52896
[TBL] [Abstract][Full Text] [Related]
7. The contribution of plasma protease inhibitors to antiplasmin activity in man.
Crawford GP; Ogston D; Douglas AS
Clin Sci Mol Med; 1976 Aug; 51(2):215-8. PubMed ID: 60190
[TBL] [Abstract][Full Text] [Related]
8. In vivo catabolism of alpha 1-proteinase inhibitor-trypsin, antithrombin III-thrombin and alpha 2-macroglobulin-methylamine.
Fuchs HE; Shifman MA; Pizzo SV
Biochim Biophys Acta; 1982 May; 716(2):151-7. PubMed ID: 6178438
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor.
Machovich R; Borsodi A; Blaskó G; Orakzai SA
Biochem J; 1977 Nov; 167(2):393-8. PubMed ID: 74248
[TBL] [Abstract][Full Text] [Related]
10. [Changes of antithrombin (antithrombin III, alpha2-macroglobulin) in various diseases (author's transl)].
Matsuda T; Ogawara M; Kodama N; Murakami M
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):261-6. PubMed ID: 70147
[No Abstract] [Full Text] [Related]
11. A method for the differential determination of plasma antithrombins.
Musumeci V; Vincenti A; Bizzi B
J Clin Pathol; 1976 Jan; 29(1):63-8. PubMed ID: 55420
[TBL] [Abstract][Full Text] [Related]
12. The role of antithrombin III, alpha 2 macroglobulin and alpha 1 antitrypsin in progressive antithrombin activity of human plasma.
Lebreton de Vonne T; Mouray H
Int J Biochem; 1980; 12(3):479-84. PubMed ID: 6158467
[No Abstract] [Full Text] [Related]
13. Effect of serum alpha2-macroglobulin on the trypsin-soybean trypsin inhibitor complex.
Ganea D; Dumitrescu A; Szegli G
Arch Roum Pathol Exp Microbiol; 1974; 33(3-4):325-33. PubMed ID: 4143177
[No Abstract] [Full Text] [Related]
14. The alpha macroglobulins of rat serum.
Gordon AH
Biochem J; 1976 Dec; 159(3):643-50. PubMed ID: 64245
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of the inactivation of human and bovine trypsins and chymotrypsins by alpha1-proteinase inhibitor and of their reactivation by alpha2-macroglobulin.
Aubry M; Bieth J
Clin Chim Acta; 1977 Aug; 78(3):371-80. PubMed ID: 69511
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of alpha1-antitrypsin and alpha2-macroglobulin in lung cancer.
Micksche M; Kokron O
Osterr Z Onkol; 1977; 3(5-6):116-9. PubMed ID: 67586
[TBL] [Abstract][Full Text] [Related]
17. Measurement of antithrombin III, alpha 2-macroglobulin and alpha 1-antitrypsin in patients with deep venous thrombosis and pulmonary embolism.
de Boer AC; van Riel LA; den Ottolander GJ
Thromb Res; 1979; 15(1-2):17-25. PubMed ID: 90398
[No Abstract] [Full Text] [Related]
18. The disappearance of enzyme-inhibitor complexes from the circulation of man.
Ohlsson K; Laurell CB
Clin Sci Mol Med; 1976 Jul; 51(1):87-92. PubMed ID: 59654
[TBL] [Abstract][Full Text] [Related]
19. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
[TBL] [Abstract][Full Text] [Related]
20. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
Travis J; Salvesen G
Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
